MANF improves cognitive function and attenuates neuroinflammation in APP/PS1 transgenic mice through the TLR4/MYD88/NF-κB signaling pathway
Yanchao Tang, Enba Zhuo, Pengman Li, Chen Wang, Xudong Hu, Xuesheng Liu, Guanghong Xu, Qiying Shen · 2025
Read MANF improves cognitive function and attenuates neuroinflammation in APP/PS1 transgenic mice through the TLR4/MYD88/NF-κB signaling pathway by Yanchao Tang, Enba Zhuo, Pengman Li, Chen Wang, Xudong Hu, Xuesheng Liu, Guanghong Xu, Qiying Shen (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13001770.txt.
Description
Yanchao Tang and co-authors test a protective protein in a mouse model of Alzheimer disease in a 2025 study. The protein, called MANF, is made under cell stress and is known to calm immune responses and cell damage. The team asked whether giving the protein could improve thinking and ease brain inflammation in mice bred to develop the disease.
From ten months of age, the mice got daily doses of the human protein for one month. Maze and fear tests checked memory, and brain tissue was checked for amyloid deposits, inflammation, and cell loss. The title reports that treatment improved cognitive function and reduced inflammation. The benefit ran through a known immune signaling path in the brain. The authors propose the protein as a candidate therapy.
Catalog record
| CREATOR | Yanchao Tang, Enba Zhuo, Pengman Li, Chen Wang, Xudong Hu, Xuesheng Liu, Guanghong Xu, Qiying Shen |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 62 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |